The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

Don’t Do It

Published Online:https://doi.org/10.1176/pn.39.10.0046

It’s nice to see that Dr. Robin Clark’s findings in your March 5 issue regarding benzodiazepine prescriptions for patients diagnosed with substance use disorders reflect my anecdotal observations in the office. It amazes me that the same physicians who understand that those with alcoholism must never imbibe alcohol will prescribe what amounts to solidified alcohol to these individuals. The results of that prescribing practice represent much of the caseload for me and my colleagues specializing in addiction treatment.

Dr. Clark was quoted as saying that “we are not suggesting that [benzodiazepines] should never be prescribed for people with substance use disorders.” Why not? The risks of prescribing sedatives to those with sedative-use disorders are well known, the benefits are short-lived and minor in comparison, and there are many excellent alternatives. Other than in very rare circumstances, benzodiazepines should never be prescribed to individuals with substance use disorders.

Providence, R.I.